Tests may detect early stages of Alzheimer's disease
Contemporary Long-Term Care Weekly, December 13, 2006
For the past two years, scientists have been developing a test to detect the earliest stage of Alzheimer's disease, reported the Pittsburgh Post-Gazette. Scientists are making progress and can now identify a series of proteins in blood or spinal fluid that may indicate if a patient has Alzheimer's disease. So far researchers have identified 23 proteins, referred to as biomarkers. They will use their findings in a clinical trial of 100 patients. The results must be duplicated in larger trials before they become the foundation for more reliable tests, reported the Post-Gazette.
Related Products
Most Popular
- Articles
-
- HIPAA Q&A: Flu shot requirement for hospital employees
- Running an effective peer review committee meeting
- HealthDataInsights posts new issues for medical necessity claims
- Sneak Peek: Effort underway to establish caseload benchmarks
- Q/A: Coding for telescopic intraocular lens
- New FAQ posted on storing laryngoscope blades
- Tip: Perform your own internal investigation prior to government audit
- HIPAA 5010 deadline extended, but threat remains, says AMA
- HHS task force: Consider privacy, security with text messages
- What does case-mix index mean to you?
- E-mailed
-
- Running an effective peer review committee meeting
- HIPAA Q&A: Flu shot requirement for hospital employees
- HHS task force: Consider privacy, security with text messages
- What does case-mix index mean to you?
- Q/A: Coding for telescopic intraocular lens
- Q/A: Correct use of modifier -PT
- Tip: Correctly code bilateral pain management procedures
- "Wall fountains" may be spreading Legionnaires to patients, visitors
- 2012 CPT code changes for ASCs: Shoulder and knee scopes and pain management
- COT basics to best
- Searched
